Both in Pharmaceuticals
Nuvectis Pharma vs Aclaris Therapeutics
Over the past year NVCT returned +190.6% and ACRS returned +55.1%; their daily moves had a correlation of 0.14.
NVCT +190.6% ACRS +55.1%Growth of $1, one year, split-adjusted
| Metric | NVCT | ACRS |
|---|---|---|
| Price | $18.48 | $3.97 |
| Market cap | $603.3M | $615.3M |
| Today | −0.48% | −0.50% |
| 1 month | −10.8% | −10.0% |
| 6 months | +116.4% | −10.0% |
| Year to date | +144.8% | +31.9% |
| 1 year | +173.0% | +69.7% |
| Revenue growth (YoY) | — | −8.3% |
| Gross margin | — | 86.6% |
| Net margin | — | −1320.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 74.9× |
| Net cash | $22.2M | $91.6M |
| Dividend yield | — | — |
| Volatility (60d) | 67.6% | 75.5% |
| Short % of float | 11.7% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).